Research & Literature

Otomycosis in iran: a review.

Gharaghani M, Seifi Z, Zarei Mahmoudabadi A

Mycopathologia 2015; (179(5-6)):415-24 doi:10.1007/s11046-015-9864-7.

Epidemiology, causative agents, and risk factors affecting human otomycosis infections.

Abdelazeem M, Gamea A, Mubarak H, Elzawawy N

Turkish journal of medical sciences 2015; (45(4)):820-6 doi:10.3906/sag-1407-17.

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

Denning DW, Cadranel J, Beigelman-Aubry C, et al.

The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.

Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.

Ohara S, Tazawa Y, Tanai C, et al.

Respiratory investigation 2016; (54(2)):92-7.

Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients.

Zhao Y, Garnaud C, Brenier-Pinchart MP, et al.

Frontiers in microbiology 2016; (7()):1164 doi:10.3389/fmicb.2016.01164.

Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".

Bauml JM, Troxel A, Epperson CN, et al.

Lung cancer (Amsterdam, Netherlands) 2016; (100()):110-113 doi:10.1016/j.lungcan.2016.08.002.

The emergence of Aspergillus species in chronic respiratory disease.

Yii AC, Koh MS, Lapperre TS, et al.

Frontiers in bioscience (Scholar edition) 2017; (9(1)):127-138 doi:10.2741/s477.

Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis.

Vehreschild JJ, Heussel CP, Groll AH, et al.

European radiology 2017; (27(8)):3275-3282 doi:10.1007/s00330-016-4717-4.

Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Urabe N, Sakamoto S, Sano G, et al.

Journal of clinical microbiology 2017; (55(6)):1738-1746 doi:10.1128/JCM.02497-16.

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.

Stott KE, Hope WW

The Journal of antimicrobial chemotherapy 2017; (72(suppl_1)):i12-i18 doi:10.1093/jac/dkx029.

Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan.

Hashimoto A, Hagiwara D, Watanabe A, et al.

Antimicrobial agents and chemotherapy 2017; (61(8)) doi:10.1128/AAC.02583-16.

Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.

Groll AH, Townsend R, Desai A, et al.

Transplant infectious disease : an official journal of the Transplantation Society 2017; (19(5)) doi:10.1111/tid.12751.

[Aspergillus in airway material : Ignore or treat?]

Salzer HJF, Lange C, Hönigl M

Der Internist 2017; (58(11)):1150-1162 doi:10.1007/s00108-017-0334-9.

Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.

Cho SY, Lee DG, Choi JK, et al.

Medicine 2017; (96(49)):e8841 doi:10.1097/MD.0000000000008841.

Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis.

de la Paz Cota BR, Cepero Vega PP, Matus Navarrete JJ, et al.

American journal of otolaryngology 2018; (39(3)):307-312 doi:10.1016/j.amjoto.2018.03.017.

The experience of patients participating in a small randomised control trial that explored two different interventions to reduce anxiety prior to an MRI scan.

Tugwell-Allsup J, Pritchard AW

Radiography (London, England : 1995) 2018; (24(2)):130-136 doi:10.1016/j.radi.2017.11.001.

Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.

Bongomin F, Harris C, Hayes G, et al.

PloS one 2018; (13(4)):e0193732 doi:10.1371/journal.pone.0193732.

[Effect observation of cleaning up the external auditory canal by otoendoscope combined with Clotrimazole Ointment in the treatment of pregnancy with otitis externa mycotica].

Wei XM, Lu L, Gao X

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2018; (32(2)):134-137 doi:10.13201/j.issn.1001-1781.2018.02.014.

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.

Alastruey-Izquierdo A, Cadranel J, Flick H, et al.

Respiration; international review of thoracic diseases 2018; (96(2)):159-170 doi:10.1159/000489474.

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.

Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al.

The Lancet. Respiratory medicine 2018; (6(10)):782-792 doi:10.1016/S2213-2600(18)30274-1.

Treatment of Aspergillosis.

Jenks JD, Hoenigl M

Journal of fungi (Basel, Switzerland) 2018; (4(3)) doi:10.3390/jof4030098.

Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.

Jović Z, Janković SM, Ružić Zečević D, et al.

European journal of drug metabolism and pharmacokinetics 2019; (44(2)):139-157 doi:10.1007/s13318-018-0513-7.

The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.

Hagiwara S, Tamura T, Satoh K, et al.

Mycopathologia 2019; (184(1)):13-21 doi:10.1007/s11046-018-0299-9.

Black aspergilli: A remaining challenge in fungal taxonomy?

D'hooge E, Becker P, Stubbe D, et al.

Medical mycology 2019; (57(6)):773-780 doi:10.1093/mmy/myy124.

New Insights into the Cyp51 Contribution to Azole Resistance in Aspergillus Section Nigri.

Pérez-Cantero A, López-Fernández L, Guarro J, Capilla J

Antimicrobial agents and chemotherapy 2019; (63(7)) doi:10.1128/AAC.00543-19.

Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.

Aguilar-Company J, Martín MT, Goterris-Bonet L, et al.

Mycoses 2019; (62(9)):765-772 doi:10.1111/myc.12950.

Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract.

Takeda K, Suzuki J, Watanabe A, et al.

Medical mycology 2020; (58(3)):310-314 doi:10.1093/mmy/myz072.

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient.

Bühler T, Medinger M, Bouitbir J, et al.

Frontiers in pharmacology 2019; (10()):645 doi:10.3389/fphar.2019.00645.

Role of the Aspergillus-Specific IgG and IgM Test in the Diagnosis and Follow-Up of Chronic Pulmonary Aspergillosis.

Li H, Rui Y, Zhou W, et al.

Frontiers in microbiology 2019; (10()):1438 doi:10.3389/fmicb.2019.01438.

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.

Hage CA, Carmona EM, Epelbaum O, et al.

American journal of respiratory and critical care medicine 2019; (200(5)):535-550 doi:10.1164/rccm.201906-1185ST.

Role of Clotrimazole in Prevention of Recurrent Otomycosis.

Kiakojuri K, Rajabnia R, Mahdavi Omran S, et al.

BioMed research international 2019; (2019()):5269535 doi:10.1155/2019/5269535.

Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.

Beck KR, Telisman L, van Koppen CJ, et al.

The Journal of steroid biochemistry and molecular biology 2020; (199()):105605 doi:10.1016/j.jsbmb.2020.105605.

Pulmonary Aspergillosis: What the Generalist Needs to Know.

El-Baba F, Gao Y, Soubani AO

The American journal of medicine 2020; (133(6)):668-674 doi:10.1016/j.amjmed.2020.02.025.

An overview of the available treatments for chronic cavitary pulmonary aspergillosis.

Sehgal IS, Dhooria S, Muthu V, et al.

Expert review of respiratory medicine 2020; (14(7)):715-727 doi:10.1080/17476348.2020.1750956.

Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.

Bongomin F, Asio LG, Baluku JB, et al.

Journal of fungi (Basel, Switzerland) 2020; (6(2)) doi:10.3390/jof6020075.

An emergency medicine-focused review of malignant otitis externa.

Long DA, Koyfman A, Long B

The American journal of emergency medicine 2020; (38(8)):1671-1678 doi:10.1016/j.ajem.2020.04.083.

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

Verweij PE, Rijnders BJA, Brüggemann RJM, et al.

Intensive care medicine 2020; (46(8)):1524-1535 doi:10.1007/s00134-020-06091-6.

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment.

Russo A, Tiseo G, Falcone M, Menichetti F

Infectious diseases and therapy 2020; (9(3)):511-524 doi:10.1007/s40121-020-00315-4.

A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis.

Chen Q, Chu H, Tao Y, et al.

The Laryngoscope 2021; (131(5)):E1640-E1646 doi:10.1002/lary.29190.

Diversity within Aspergillus niger Clade and Description of a New Species: Aspergillus vinaceus sp. nov.

Silva JJD, Iamanaka BT, Ferranti LS, et al.

Journal of fungi (Basel, Switzerland) 2020; (6(4)) doi:10.3390/jof6040371.

Skull Base Osteomyelitis: A Comprehensive Imaging Review.

Chapman PR, Choudhary G, Singhal A

AJNR. American journal of neuroradiology 2021; (42(3)):404-413 doi:10.3174/ajnr.A7015.

Otomycosis in Africa: Epidemiology, diagnosis and treatment.

Sangaré I, Amona FM, Ouedraogo RW, et al.

Journal de mycologie medicale 2021; (31(2)):101115 doi:10.1016/j.mycmed.2021.101115.

Serology anno 2021-fungal infections: from invasive to chronic.

Lass-Flörl C, Samardzic E, Knoll M

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2021; (27(9)):1230-1241 doi:10.1016/j.cmi.2021.02.005.

Different repartition of the cryptic species of black aspergilli according to the anatomical sites in human infections, in a French University hospital.

Gits-Muselli M, Hamane S, Verillaud B, et al.

Medical mycology 2021; (59(10)):985-992 doi:10.1093/mmy/myab027.

Unusual case of chronic cavitary pulmonary aspergillosis presenting as spontaneous pneumothorax in an immunocompromised man.

S Kumar S, Ray A, Vikram NK, Vyas S

BMJ case reports 2021; (14(8)) doi:10.1136/bcr-2021-241655.

Utility of St. George's respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis.

Bongomin F, Otu A

Therapeutic advances in infectious disease 2021; (8()):20499361211034643 doi:10.1177/20499361211034643.

Detection of Aspergillus DNA in BALF by Real-time PCR and Galactomannan Antigen for the Early Diagnosis of Chronic Pulmonary Aspergillosis.

Ye F, Zeng P, Li Z, et al.

Annals of clinical and laboratory science 2021; (51(5)):698-704.

The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study.

Takeda K, Suzuki J, Watanabe A, et al.

Mycoses 2022; (65(2)):164-170 doi:10.1111/myc.13397.

A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).

Setianingrum F, Rozaliyani A, Adawiyah R, et al.

Thorax 2022; (77(8)):821-828 doi:10.1136/thoraxjnl-2020-216464.

Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature.

Sivasubramanian G, Chandrasekar PH

Expert opinion on pharmacotherapy 2022; (23(5)):543-549 doi:10.1080/14656566.2022.2032645.

Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis.

Zhong H, Wang Y, Gu Y, et al.

Frontiers in medicine 2022; (9()):811807 doi:10.3389/fmed.2022.811807.

Clinical Presentations, Cluster Analysis and Laboratory-Based Investigation of Aspergillus Otomycosis-A Single Center Experience.

Bojanović M, Ignjatović A, Stalević M, et al.

Journal of fungi (Basel, Switzerland) 2022; (8(3)) doi:10.3390/jof8030315.

Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.

Sehgal IS, Dhooria S, Muthu V, et al.

The Lancet. Infectious diseases 2022; (22(7)):1052-1061 doi:10.1016/S1473-3099(22)00057-3.

Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil.

Volpe-Chaves CE, Venturini J, B Castilho S, et al.

Mycoses 2022; (65(7)):715-723 doi:10.1111/myc.13465.

EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis.

Sprute R, Van Braeckel E, Flick H, et al.

The Journal of antimicrobial chemotherapy 2022; (78(1)):225-231 doi:10.1093/jac/dkac378.

Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.

Ogawa Y, Murata K, Hasegawa K, et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2023; (29(3)):239-243 doi:10.1016/j.jiac.2022.11.001.

Review of Recurrent Otomycosis and Clotrimazole in Its Treatment.

Haq M, Deshmukh P

Cureus 2022; (14(10)):e30098 doi:10.7759/cureus.30098.

Pulmonary aspergillosis: diagnosis and treatment.

Lamoth F, Calandra T

European respiratory review : an official journal of the European Respiratory Society 2022; (31(166)) doi:10.1183/16000617.0114-2022.

The clinical significance of Aspergillus-positive respiratory samples.

Katriina P, Veli-Jukka A, Ulla H

Mycoses 2023; (66(5)):387-395 doi:10.1111/myc.13566.

Role of COPD in a case of fatal Aspergillus niger tracheobronchitis.

Ashby T, Green K, Burcher KM, Louis M

BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-251807.

A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus.

Ito Y, Inoue N, Kaneko N, et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2023; (29(8)):809-811 doi:10.1016/j.jiac.2023.04.014.

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.

Stemler J, Többen C, Lass-Flörl C, et al.

Journal of fungi (Basel, Switzerland) 2023; (9(4)) doi:10.3390/jof9040500.

Diagnostic Laboratory Features and Performance of an Aspergillus IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort.

Zhu RS, Zhou LH, Cheng JH, et al.

Microbiology spectrum 2023; (11(3)):e0026423 doi:10.1128/spectrum.00264-23.

The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda.

Namusobya M, Bongomin F, Mukisa J, et al.

Mycopathologia 2023; (188(5)):713-720 doi:10.1007/s11046-023-00741-1.

Systematic review and meta-analysis of galactomannan antigen testing in serum and bronchoalveolar lavage for the diagnosis of chronic pulmonary aspergillosis: defining a cutoff.

de Oliveira VF, Silva GD, Taborda M, et al.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2023; (42(9)):1047-1054 doi:10.1007/s10096-023-04639-0.

Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings.

Takeda K, Suzuki J, Sasaki Y, et al.

Medical mycology journal 2023; (64(4)):95-98 doi:10.3314/mmj.23-004.

Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.

Evans TJ, Lawal A, Kosmidis C, Denning DW

Seminars in respiratory and critical care medicine 2024; (45(1)):88-101 doi:10.1055/s-0043-1776914.

Molecular Analysis for Potential Hospital-Acquired Infection Caused by Aspergillus Tubingensis Through the Environment.

Tanamachi C, Iwahashi J, Togo A, et al.

The Kurume medical journal 2024; (69(3.4)):185-193 doi:10.2739/kurumemedj.MS6934013.

Fungal Otitis Externa (Otomycosis) Associated with Aspergillus Flavus: A Case Image.

MacDonald WW, Wakely PE, Kalmar JR, Argyris PP

Head and neck pathology 2024; (18(1)):5 doi:10.1007/s12105-023-01606-1.

Clinicomycological Study of the Spectrum of Pulmonary Aspergillosis at a Tertiary Care Hospital in Central India.

Krishna A, Keche A, Tg R, Das P

Cureus 2024; (16(3)):e56147 doi:10.7759/cureus.56147.

Clinicopathological study of otomycosis in a tertiary hospital in South-west Nigeria.

Sogebi OA, Oyewole EA, Osinupebi OA

African health sciences 2024; (24(1)):69-75 doi:10.4314/ahs.v24i1.9.

Approaches for posaconazole therapeutic drug monitoring and their clinical benefits.

Wang S, Li C, Dong Y, Dong W

European journal of clinical pharmacology 2024; (80(12)):1845-1855 doi:10.1007/s00228-024-03756-9.

Topical Antibiotic-Induced Otomycosis - a Systematic Review of Aetiology and Risk Factors.

Pereira M, Rao K, Sharin F, et al.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2024; (76(5)):3766-3776 doi:10.1007/s12070-024-04852-z.

Approach to otitis externa.

Ellis J, De La Lis A, Rosen E, et al.

Canadian family physician Medecin de famille canadien 2024; (70(10)):617-623 doi:10.46747/cfp.7010617.

Aspergillus otitis externa: A retrospective study of predisposing factors, treatment, and complications.

Viljanen M, Saarinen R, Hafrén L

Laryngoscope investigative otolaryngology 2024; (9(5)):e70028 doi:10.1002/lio2.70028.

Clinical applications of immunoglobulin G against different individual Aspergillus species for the diagnosis of chronic pulmonary aspergillosis among at-risk populations.

Keng LT, Lin CC, Wu CW, et al.

Pathogens and global health 2024; (118(7-8)):574-581 doi:10.1080/20477724.2024.2424489.

Misdiagnosis of a fungus ball in the middle ear as chronic suppurative otitis media.

Yang YY, Guo LR

Journal of infection in developing countries 2024; (18(11)):1793-1797 doi:10.3855/jidc.19395.

Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis.

Takazono T, Saito Y, Tashiro M, et al.

Infectious diseases and therapy 2025; (14(1)):245-259 doi:10.1007/s40121-024-01094-y.

Unusual Presentation of a Rare Disease: A Case Report of Fungal Necrotizing Otitis Media and Mastoiditis.

Mousavi Mohammadi E, Rajati M, Zarrinfar H

Clinical case reports 2025; (13(1)):e70101 doi:10.1002/ccr3.70101.

The Conundrum of Computed Tomography Findings in Chronic Pulmonary Aspergillosis: Insights From 103 Cases.

Garg M, Bhatia H, Sehgal I, et al.

Journal of thoracic imaging 2025; (40(5)) doi:10.1097/RTI.0000000000000828.

Isolated brain abscess caused by Aspergillus tubingensis in a patient with alcoholic liver cirrhosis.

Inaba T, Minami K, Ishioka H, et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2025; (31(5)):102691 doi:10.1016/j.jiac.2025.102691.

Epidemiological characteristics of patients with invasive pulmonary aspergillosis infected with Aspergillus fumigatus from a tertiary hospital in Ningxia, China.

Kang Y, Li Q, Ma W, et al.

Scientific reports 2025; (15(1)):13036 doi:10.1038/s41598-025-97587-y.

A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).

Rozaliyani A, Setianingrum F, Isbaniah F, et al.

Journal of fungi (Basel, Switzerland) 2025; (11(5)) doi:10.3390/jof11050329.

Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005).

Wichmann D, Hoenigl M, Koehler P, et al.

Infection 2025; (53(4)):1299-1310 doi:10.1007/s15010-025-02572-2.

Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species-Specific IgG.

Sehgal IS, Agarwal R, Muthu V, et al.

Mycoses 2025; (68(9)):e70107 doi:10.1111/myc.70107.

Transitioning to Patient-Centered Radiology: Exploring the Feasibility of Patient-Radiologist Video Imaging Review: A Pilot Study.

Steinberger S, Valinsky D, O'Neill B, et al.

Journal of the American College of Radiology : JACR 2026; (23(5)):770-778 doi:10.1016/j.jacr.2025.11.026.

Otomycosis in Southern China: a retrospective analysis of clinical presentation, otoendoscopic features, and causative pathogens.

Wang Q, Xu D, Li Y, et al.

Mycopathologia 2025; (191(1)):15 doi:10.1007/s11046-025-01036-3.

Aspergillus Serology Predicts Relapse in Chronic Pulmonary Aspergillosis: Implications for Personalised Follow-Up Strategies.

Choyce A, Colombo S, Cyriac C, et al.

Mycoses 2026; (69(2)):e70156 doi:10.1111/myc.70156.

Non-fumigatus Aspergillus-associated pulmonary events: a diagnostic challenge.

Godet C, Joste V, Frat J-P, et al.

Journal of clinical microbiology 2026; (64(4)):e0016326 doi:10.1128/jcm.00163-26.

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

Denning DW, Rogers TR, Takazono T, et al.

American journal of respiratory and critical care medicine 2026; doi:10.1093/ajrccm/aamag310.

Reduced Activity of Triazole Antifungal Agents Against Aspergillus tubingensis From a Global Collection of Genomically-Characterized Aspergillus Section Nigri Clinical Isolates (2020-2023).

Kimbrough JH, Winkler ML, Karr MH, et al.

Mycoses 2026; (69(7)):e70197 doi:10.1111/myc.70197.